Status:
UNKNOWN
Endovascular Treatment in Ischemic Stroke Follow-up Evaluation
Lead Sponsor:
Hopital Foch
Conditions:
Stroke, Acute
Eligibility:
All Genders
18+ years
Brief Summary
Study like register with biomarkers samples for patient experiencing acute ischemic stroke, to assess clinical outcomes and different factors that may affect the clinical outcomes.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 18 and older (i.e., candidates must have had their 18th birthday)
- Neuroimaging demonstrates acute ischemic stroke with large vessel proximal with the use of neuro-thrombectomy devices intended to restore blood flow
- No upper or lower limits of the neurological severity at baseline (NIHSS).
- With or without intravenous thrombolysis
- Oral informed consent (patient and/or trustworthy person)
- Non-inclusion Criteria:
- Pregnant or breast-feeding women
- Patient benefiting from a legal protection
- Non-membership of a national insurance scheme
Exclusion
Key Trial Info
Start Date :
June 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT03776877
Start Date
June 26 2018
End Date
December 1 2022
Last Update
August 3 2022
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux
Bordeaux, France
2
CHU de Caen
Caen, France
3
Hôpital le Kremlin-Bicètre - APHP
Le Kremlin-Bicêtre, France
4
CHU Dupuytren
Limoges, France, 87042